Relation between Tc-99m sestamibi uptake and biological factors in hyperparathyroidism

Annals of Nuclear Medicine

Volumn 19, Issue 5, 2005, Pages 387-392

  Cermik, Tevfik Fikret ^a   Puyan, Fulya Oz ^a   Sezer, Atakan ^a   Firat, Mehmet Fatih ^a   Berkarda, Sakir ^a  

^a TRAKYA UNIVERSITY   (Turkey)

Author keywords

Calcium; Hyperparathyroidism; MIBI; Oxyphil cell; Phosphorus

Indexed keywords

CALCIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PARATHYROID HORMONE; PHOSPHORUS;

AGED; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG UPTAKE; FEMALE; HUMAN; HYPERPARATHYROIDISM; MALE; ORGAN SIZE; PARATHYROID GLAND; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; THYROID PARAFOLLICULAR CELL;

EID: 24644481104     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03027403     Document Type: Article

References (27)

1. Giordano A, Rubello D, Casara D. New trends in parathyroid scintigraphy. Eur J Nucl Med 2001; 28: 1409-1420.
2. 99mTc sestamibi. Nucl Med Commun 2003; 24: 485-488.
3. Holman BL, Marsh JD, Jones AG. Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 1990; 31: 464-472.
4. Piwnica-Worms D, Kronauge JF, Delmon L, Chiu ML, Kronauge JF, Piwnica-Worms D. Effect of mitochondrial and plasma membrane potentials on accumulation of hexakis (2-methoxyisobutylisonitrile)technetium(I) in cultured mouse fibroblasts. J Nucl Med 1990; 31: 1646-1653.
5. Delmon-Moingeon LI, Piwnica-Worms D, Van den Abbeele AD, Holman BL, Davison A, Jones AG. Uptake of the cation hexakis (2-methoxyisobutylisonitrile)- technetium-99m by human carcinoma cell lines in vitro. Cancer Res 1990; 50: 2198-2202.
6. Carvalho PA, Chiu ML, Kronauge JF, Kawamura M, Jones AG, Holman BL, et al. Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. J Nucl Med 1992; 33: 1516-1522.
7. Pons F, Torregrosa JV, Fuster D. Biological factors influencing parathyroid localization. Nucl Med Commun 2003; 24: 121-124.
8. Ghandur-Mnaymneh L, Kimura N. The parathyroid adenoma. A histopathologic definition with a study of 172 cases of primary hyperparathyroidism. Am J Pathol 1984; 115: 70-83.
9. Greenspan BS, Brown ML, Dillehay GL, McBiles M, Sandler MP, Seabold JE, Sisson JC. Procedure guideline for parathyroid scintigraphy 2.0. Society of Nuclear Medicine Procedure Guidelines Manual 2001. Resion, VA; Society of Nuclear Medicine, 2001: 19-23.
10. Arbab AS, Koizumi K, Hemmi A, Toyama K, Arai T, Yoshitomi T, et al. Tc-99m-MIBI scintigraphy for detecting parathyroid adenoma and hyperplasia. Ann Nucl Med 1997; 11: 45-49.
11. Piga M, Bolasco P, Satta L, Altieri P, Loi G, Nicolosi A, et al. Double phase parathyroid technetium-99m-MIBI scintigraphy to identify functional autonomy in secondary hyperparathyroidism. J Nucl Med 1996; 37: 565-569.
12. Bhatnagar A, Vezza PR, Bryan JA, Atkins FB, Ziessman HA. Technetium-99m-sestamibi parathyroid scintigraphy: effect of P-glycoprotein, histology and tumor size on detectability. J Nucl Med 1998; 39: 1617-1620.
13. Torregrosa JV, Fernandez-Cruz L, Canalejo A, Vidal S, Astudillo E, Almaden Y, et al. (99m)Tc-sestamibi scintigraphy and cell cycle in parathyroid glands of secondary hyperparathyroidism. World J Surg 2000; 24: 1386-1390.
14. 99mTc-MIBI scintigraphy of parathyroid adenomas and its relation to tumour size and oxyphil cell abundance. Eur J Nucl Med 2001; 28: 209-213.
15. 99mTc-MIBI in functional studies of the parathyroid gland? Nephrol Dial Transplant 1998; 13 Suppl 3: 33-36.
16. Torregrosa JV, Palomar MR, Pons F, Sabater L, Gilabert R, Llovera J, et al. Has double-phase MIBI scintigraphy usefulness in the diagnosis of hyperparathyroidism? Nephrol Dial Transplant 1998; 13 Suppl 3: 37-40.
17. Hung GU, Wang SJ, Lin WY. Tc-99m MIBI parathyroid scintigraphy and intact parathyroid hormone levels in hyperparathyroidism. Clin Nucl Med 2003; 28: 180-185.
18. Parikshak M, Castillo ED, Conrad MF, Talpos GB. Impact of hypercalcemia and parathyroid hormone level on the sensitivity of preoperative sestamibi scanning for primary hyperparathyroidism. Am Surg 2003; 69: 393-399.
19. Carpentier A, Jeannotte S, Verreault J, Lefebvre B, Bisson G, Mongeau CJ, et al. Preoperative localization of parathyroid lesions in hyperparathyroidism: relationship between technetium-99m-MIBI uptake and oxyphil cell content. J Nucl Med 1998; 39: 1441-1444.
20. Staudenherz A, Abela C, Niederle B, Steiner E, Helbich T, Puig S et al. Comparison and histopathological correlation of three parathyroid imaging methods in a population with a high prevalence of concomitant thyroid diseases. Eur J Nucl Med 1997; 24: 143-149.
21. Lane MJ, Desser TS, Weigel RJ, Jeffrey RB Jr. Use of color and power Doppler sonography to identify feeding arteries associated with parathyroid adenomas. AJR Am J Roentgenol 1998; 171: 819-823.
22. Tanaka Y, Funahashi H, Imai T, Seo H, Tominaga Y, Takagi H. Oxyphil cell function in secondary parathyroid hyperplasia. Nephron 1996; 73: 580-586.
23. 99mTc-SestaMIBI scan in the diagnostic evaluation of thyroid nodules with oncocytic cytology. Eur J Endocrinol 2003; 149: 493-498.
24. Vattimo A, Bertelli P, Cintorino M, Burroni L, Volterrani D, Vella A. Identification of Hurthle cell tumor by single-injection, double-phase scintigraphy with technetium-99m-sestamibi. J Nucl Med 1995; 36: 778-782.
25. Sarikaya A, Huseyinova G, Irfanoglu ME, Erkmen N, Cermik TF, Berkarda S. The relationship between 99-Tc(m)-sestamibi uptake and ultrastructural cell types of thyroid tumours. Nucl Med Commun 2001; 22: 39-44.
26. Thompson GB, Mullan BP, Grant CS, Gorman CA, van Heerden JA, O'Connor MK, et al. Parathyroid imaging with technetium-99m-sestamibi: an initial institutional experience. Surgery 1994; 116: 966-972.
27. Westreich RW, Brandwein M, Mechanick JI, Bergman DA, Urken ML. Preoperative parathyroid localization: correlating false-negative technetium 99m sestamibi scans with parathyroid disease. Laryngoscope 2003; 113: 567-572.